Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Executives discuss the COVID-19 financial fallout and what future subsequent peaks might look like for health systems.

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Social distancing may be necessary for two years or more. Here's where remote care comes into play.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Health plans must maintain a competitive portfolio and double-down on their offerings.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Principal, FSA, MAAA, Oliver Wyman

Cost Transformation Amidst Uncertainty

Establish and aim towards a North Star to ensure your organization heads in the direction you want it to.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe

An overview of mix shift modeling, including varying recovery scenarios, margin impact, and possible future legislation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Part 3: One Size Does Not Fit All

A closer look at unemployment, member migration, and financial impact amidst an ever-changing pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Considerations for the pricing of health insurance products amidst a global crisis.

Partner, Health & Life Sciences, Oliver Wyman
Senior Advisor, Health & Life Sciences, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Our review of 20 payer pandemic responses shows most consumer outreaches demand more empathy. Let's flip the switch.

Partner, Health & Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman

Insights in your inbox

Subscribe